1 |
Piancatelli D, Aureli A, Sebastiani P, Colanardi A, Del Beato T, Del Cane L, Sucapane P, Marini C, Di Loreto S. Gene- and Gender-Related Decrease in Serum BDNF Levels in Alzheimer's Disease. Int J Mol Sci 2022;23. [PMID: 36498925 DOI: 10.3390/ijms232314599] [Reference Citation Analysis]
|
2 |
Hamid M, Mansoor S, Amber S, Zahid S. A quantitative meta-analysis of vitamin C in the pathophysiology of Alzheimer’s disease. Front Aging Neurosci 2022;14:970263. [DOI: 10.3389/fnagi.2022.970263] [Reference Citation Analysis]
|
3 |
Botchway BO, Okoye FC, Chen Y, Arthur WE, Fang M. Alzheimer Disease: Recent Updates on Apolipoprotein E and Gut Microbiome Mediation of Oxidative Stress, and Prospective Interventional Agents. Aging Dis 2022;13:87-102. [PMID: 35111364 DOI: 10.14336/AD.2021.0616] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
4 |
Bazrgar M, Khodabakhsh P, Prudencio M, Mohagheghi F, Ahmadiani A. The role of microRNA-34 family in Alzheimer's disease: A potential molecular link between neurodegeneration and metabolic disorders. Pharmacol Res 2021;172:105805. [PMID: 34371173 DOI: 10.1016/j.phrs.2021.105805] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 6.5] [Reference Citation Analysis]
|
5 |
Nitzan K, Ellenbogen L, Beniamin T, Sarne Y, Doron R. An ultra-low dose of Δ9-tetrahydrocannabinol improves Alzheimer’s Disease-related cognitive deficits.. [DOI: 10.1101/2021.08.22.457252] [Reference Citation Analysis]
|
6 |
Xiong N, Schiller MR, Li J, Chen X, Lin Z. Severe COVID-19 in Alzheimer's disease: APOE4's fault again? Alzheimers Res Ther 2021;13:111. [PMID: 34118974 DOI: 10.1186/s13195-021-00858-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|